Clinical Trials on Postmenopausal Endometrium in United Kingdom
Total 956 results
-
Yale UniversityGenentech, Inc.CompletedEndometrial CancerUnited States
-
Carilion ClinicVirginia Polytechnic Institute and State UniversityRecruitingTelemedicine | CounselingUnited States
-
Northwestern UniversityCompletedCervical Cancer | Gynecologic Cancer | Ovarian Cancer | Endometrial Cancer | Uterine CancerUnited States
-
St. Luke's-Roosevelt Hospital CenterCompletedEndometrial CancerUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent Endometrial Carcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v8 | Stage IV Uterine Corpus Cancer AJCC v8 | Stage IVA Uterine Corpus Cancer AJCC v8 | Stage IVB Uterine Corpus Cancer AJCC v8 | Refractory Endometrial Carcinoma | Refractory... and other conditionsUnited States
-
Queensland Centre for Gynaecological CancerThe University of QueenslandRecruitingSurgery | Sentinel Lymph Node | Endometrial Cancer Stage IAustralia, United States, Brazil, Singapore, India
-
University of Maryland, BaltimoreRecruitingEndometrial CancerUnited States
-
ART Fertility Clinics LLCTerminatedInfertility, Female | IVF | Endometrial Disorder | Pregnancy EarlyUnited Arab Emirates
-
Power Life Sciences Inc.Not yet recruiting
-
Washington University School of MedicineRecruitingEndometrial CancerUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Endometrial CarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest...TerminatedEndometrial CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States
-
Massachusetts General HospitalWithdrawnEndometrial Mixed Cell Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Cytoreductive Surgery | High Grade Serous Carcinoma | Grade 3 Endometrial Endometrioid AdenocarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States
-
AbbVieTerminated
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Canada
-
University of UtahRecruitingEndometrial CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedEndometrial CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Active, not recruitingEndometrial Cancer | SurvivorshipUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Positive | Progesterone Receptor Positive | Postmenopausal | KIT Positive | PDGFR PositiveUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedCervical Cancer | Endometrial Cancer | Radiation Toxicity | Sexuality and Reproductive IssuesUnited States
-
SCRI Development Innovations, LLCEli Lilly and Company; GlaxoSmithKlineCompletedCervical Cancer | Ovarian Cancer | Lung Cancer | Endometrial CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedEndometrial CarcinomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedEndometrial CancerUnited States, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedEndometrial CancerUnited States, Norway
-
University of OklahomaMerck Sharp & Dohme LLCRecruitingEndometrial CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Canada
-
Indiana UniversityCompletedCervical Cancer | Endometrial CancerUnited States
-
University of PittsburghTerminatedNon-small Cell Lung Cancer | Postmenopausal WomenUnited States
-
GOG FoundationNovartis PharmaceuticalsActive, not recruitingAdvanced, Persistent, or Recurrent Endometrial CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Leap Therapeutics,...Recruiting
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingEndometrial CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Not yet recruitingStage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage IV Uterine Corpus CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedCervix Cancer | Endometrial Carcinoma | Carcinoma of the UterusUnited States
-
Novadaq Technologies ULC, now a part of StrykerCompletedCervical Cancer | Endometrial Cancer | Uterine CancerUnited States, Canada, Puerto Rico
-
Fox Chase Cancer CenterOncoceutics, Inc.Terminated
-
M.D. Anderson Cancer CenterCompletedEndometrial CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States
-
Case Comprehensive Cancer CenterCompletedEndometrial Cancer | Weight ChangesUnited States
-
National Center for Complementary and Integrative...CompletedCardiovascular Diseases | Breast Cancer | Osteoporosis | Endometrial CancerUnited States
-
St George's, University of LondonTerminatedEndometrial Cancer | Hereditary Non-polyposis Colon Cancer (hmsh2, hmlh1, hpms1, hpms2)United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Mixed Adenocarcinoma | Grade 3 Endometrial Endometrioid Adenocarcinoma | Malignant Mixed Mesodermal (Mullerian) TumorUnited States
-
New York University Cancer InstituteNational Cancer Institute (NCI)CompletedSarcoma | Endometrial CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Canada
-
NRG OncologyNational Cancer Institute (NCI)CompletedEndometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Metastatic Endometrioid AdenocarcinomaUnited States